Predict your next investment

Venture Capital
emvllp.com

See what CB Insights has to offer

Investments

65

Portfolio Exits

13

Funds

2

About Emergent Medical Partners

Emergent Medical Partners, founded in 2007, is a life sciences investment firm that focuses on seed and early stage investments. Its focus is on early stage companies and our expertise encompasses all areas of medicine, including cardiovascular and general surgery, orthopedic surgery, cardiology, radiology, oncology, obesity, gynecology, oncology, and sleep disorders.

Emergent Medical Partners Headquarter Location

205 Sourth Drive Suite B

Mountain View, California, 94040,

United States

650-851-0091

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Emergent Medical Partners News

Standard Bariatrics Raises $35M in Series B Funding

Jun 1, 2021

Standard Bariatrics, Inc. , a Cincinnati, OH-based bariatric surgery medical device company, raised $35M in Series B funding. The round was led by U.S. Venture Partners (USVP) with participation from new investor River Cities Capital, RiverVest® Venture Partners, Hatteras Venture Partners, Queen City Angels and Emergent Medical Partners. Led by CEO Matt Sokany, Standard Bariatrics has developed the Titan SGS™, a design that offers surgeons performing sleeve gastrectomy, a bariatric surgical procedure for obesity disease. In April of 2021, the company’s Titan SGS™ stapler received clearance from the US Food and Drug Administration allowing the device to be used in bariatric surgery requiring the creation of sleeve pouch anatomy (sleeve gastrectomy). The submission was supported by the completion of a successful 62-patient study. FinSMEs 01/06/2021

Emergent Medical Partners Investments

65 Investments

Emergent Medical Partners has made 65 investments. Their latest investment was in Standard Bariatrics as part of their Series B on June 6, 2021.

CBI Logo

Emergent Medical Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/1/2021

Series B

Standard Bariatrics

$35M

No

8

3/16/2021

Series B - II

BioTrace Medical

$10.87M

No

1

5/6/2020

Series C

Arterys

$28M

No

2

3/19/2020

Series E

Subscribe to see more

$99M

Subscribe to see more

10

8/27/2019

Debt

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/1/2021

3/16/2021

5/6/2020

3/19/2020

8/27/2019

Round

Series B

Series B - II

Series C

Series E

Debt

Company

Standard Bariatrics

BioTrace Medical

Arterys

Subscribe to see more

Subscribe to see more

Amount

$35M

$10.87M

$28M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

8

1

2

10

10

Emergent Medical Partners Portfolio Exits

13 Portfolio Exits

Emergent Medical Partners has 13 portfolio exits. Their latest portfolio exit was EBR Systems on November 24, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/24/2021

IPO

$99M

Public

2

8/14/2019

Asset Sale

$99M

1

5/9/2019

Acquired

$99M

1

10/1/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

9/26/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/24/2021

8/14/2019

5/9/2019

10/1/2018

9/26/2018

Exit

IPO

Asset Sale

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

2

1

1

10

10

Emergent Medical Partners Fund History

2 Fund Histories

Emergent Medical Partners has 2 funds, including Emergent Medical Partners II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/10/2014

Emergent Medical Partners II

Early-Stage Venture Capital

Closed

$60.15M

1

3/1/2012

Emergent Medical Partners I

Subscribe to see more

Subscribe to see more

$99M

0

Closing Date

9/10/2014

3/1/2012

Fund

Emergent Medical Partners II

Emergent Medical Partners I

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Status

Closed

Subscribe to see more

Amount

$60.15M

$99M

Sources

1

0

Emergent Medical Partners Team

4 Team Members

Emergent Medical Partners has 4 team members, including current Managing Director, Bob Brownell.

Name

Work History

Title

Status

Bob Brownell

Managing Director

Current

Thomas Fogarty

Managing Director

Current

Kirt Kirtland

Managing Director

Current

Allan W. May

Managing Director

Former

Name

Bob Brownell

Thomas Fogarty

Kirt Kirtland

Allan W. May

Work History

Title

Managing Director

Managing Director

Managing Director

Managing Director

Status

Current

Current

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.